Cervical Cancer Vaccines Now Less Than $5 Per Dose In Poor Nations

Pharmaceutical companies GlaxoSmithKline and Merck announced Thursday that they would be manufacturing and distributing their vaccines against cervical cancer in poor nations for under $5 per dose. Although this charitable move makes the vaccine more accessible to the poor on a global scale, it is met with several opinions from how encouraging the vaccine would impact young girls, to the price still not being low enough.

http://bionews-tx.com/news/2013/05/10/cervical-cancer-vaccines-now-less-than-5-per-dose-in-poor-nations/

Baylor Researcher Part Of Research Team Revealing Protective Properties of Influenza Vaccines

Baylor Researcher Part Of Research Team Revealing Protective Properties of Influenza Vaccines

http://bionews-tx.com/news/2013/03/24/baylor-researcher-part-of-research-team-revealing-protective-properties-of-influenza-vaccines/